Earlier this month, Novo Nordisk said it expects continued competition from copycat version Wegovy this year and rising pressure from main U.S. rival, Eli Lilly
Novo Nordisk to offer Ozempic at $499 per month to eligible US customers
One America News Network
Aug 18, 2025 | 10:38 AM
We use cookies for various purposes including analytics and marketing. By continuing to use this service, you agree to use cookies by us and our third-party service providers as described in the Privacy Policy.